264 related articles for article (PubMed ID: 32133437)
1. Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?
Chong J; Ho AF; Yap J; Bulluck H; Hausenloy DJ
Cond Med; 2019 Oct; 2(5):204-212. PubMed ID: 32133437
[TBL] [Abstract][Full Text] [Related]
2. Coronary Artery Vasospasm Induced by 5-fluorouracil: Proposed Mechanisms, Existing Management Options and Future Directions.
Chong JH; Ghosh AK
Interv Cardiol; 2019 May; 14(2):89-94. PubMed ID: 31178935
[TBL] [Abstract][Full Text] [Related]
3. The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease.
Fabin N; Bergami M; Cenko E; Bugiardini R; Manfrini O
J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268333
[TBL] [Abstract][Full Text] [Related]
4. 5-Fluorouracil-related Cardiotoxicity with Coronary Vasospasms.
Faheem B; Kania B; Ashkar H; Bondili L; Maroules M
J Community Hosp Intern Med Perspect; 2022; 12(5):71-74. PubMed ID: 36262502
[TBL] [Abstract][Full Text] [Related]
5. Fluoropyrimidine-Associated Cardiotoxicity.
Kanduri J; More LA; Godishala A; Asnani A
Cardiol Clin; 2019 Nov; 37(4):399-405. PubMed ID: 31587781
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
Karakulak UN; Aladağ E; Maharjan N; Övünç K
Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity.
Polk A; Vistisen K; Vaage-Nilsen M; Nielsen DL
BMC Pharmacol Toxicol; 2014 Sep; 15():47. PubMed ID: 25186061
[TBL] [Abstract][Full Text] [Related]
8. A Case of 5-Fluorouracil-Induced Cardiac Arrest.
Ray JC; Cho P; Dragon M; Graham CG
J Emerg Med; 2016 Jan; 50(1):e1-6. PubMed ID: 26482827
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Remote Ischemic Conditioning and Glyceryl Trinitrate on Perioperative Myocardial Injury in Cardiac Bypass Surgery Patients: Rationale and Design of the ERIC-GTN Study.
Hamarneh A; Sivaraman V; Bulluck H; Shanahan H; Kyle B; Ramlall M; Chung R; Jarvis C; Xenou M; Ariti C; Cordery R; Yellon DM; Hausenloy DJ
Clin Cardiol; 2015 Nov; 38(11):641-6. PubMed ID: 26412308
[TBL] [Abstract][Full Text] [Related]
10. A case of 5-fluorouracil cardiotoxicity simulating acute myocardial infarction.
Mizuno Y; Hokamura Y; Kimura T; Kimura Y; Kaikita K; Yasue H
Jpn Circ J; 1995 May; 59(5):303-7. PubMed ID: 7596036
[TBL] [Abstract][Full Text] [Related]
11. Remote ischemic conditioning: the cardiologist's perspective.
Schmidt MR; Sloth AD; Johnsen J; Bøtker HE
J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):667-74. PubMed ID: 23114270
[TBL] [Abstract][Full Text] [Related]
12. Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study--A Single-Center, Blinded, Randomized Controlled Trial.
Chung R; Maulik A; Hamarneh A; Hochhauser D; Hausenloy DJ; Walker JM; Yellon DM
Clin Cardiol; 2016 Feb; 39(2):72-82. PubMed ID: 26807534
[TBL] [Abstract][Full Text] [Related]
13. The reduction of infarct size--forty years of research.
Ferreira R
Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
[TBL] [Abstract][Full Text] [Related]
14. Acute, delayed and chronic remote ischemic conditioning is associated with downregulation of mTOR and enhanced autophagy signaling.
Rohailla S; Clarizia N; Sourour M; Sourour W; Gelber N; Wei C; Li J; Redington AN
PLoS One; 2014; 9(10):e111291. PubMed ID: 25347774
[TBL] [Abstract][Full Text] [Related]
15. Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor.
Lieder HR; Tsoumani M; Andreadou I; Schrör K; Heusch G; Kleinbongard P
Cardiovasc Drugs Ther; 2023 Oct; 37(5):865-876. PubMed ID: 35595877
[TBL] [Abstract][Full Text] [Related]
16. Influence of long-term treatment with glyceryl trinitrate on remote ischemic conditioning.
Hauerslev M; Mørk SR; Pryds K; Contractor H; Hansen J; Jespersen NR; Johnsen J; Heusch G; Kleinbongard P; Kharbanda R; Bøtker HE; Schmidt MR
Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H150-H158. PubMed ID: 29569958
[TBL] [Abstract][Full Text] [Related]
17. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction.
White SK; Frohlich GM; Sado DM; Maestrini V; Fontana M; Treibel TA; Tehrani S; Flett AS; Meier P; Ariti C; Davies JR; Moon JC; Yellon DM; Hausenloy DJ
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):178-188. PubMed ID: 25240548
[TBL] [Abstract][Full Text] [Related]
18. Bioassays of Humoral Cardioprotective Factors Released by Remote Ischemic Conditioning in Patients Undergoing Coronary Artery Bypass Surgery.
Lieder HR; Tüller P; Braczko F; Zandi A; Kamler M; Thielmann M; Heusch G; Kleinbongard P
J Cardiovasc Pharmacol Ther; 2022; 27():10742484221097273. PubMed ID: 35510644
[TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study.
Kosmas C; Kallistratos MS; Kopterides P; Syrios J; Skopelitis H; Mylonakis N; Karabelis A; Tsavaris N
J Cancer Res Clin Oncol; 2008 Jan; 134(1):75-82. PubMed ID: 17636329
[TBL] [Abstract][Full Text] [Related]
20. Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial.
Hausenloy DJ; Candilio L; Laing C; Kunst G; Pepper J; Kolvekar S; Evans R; Robertson S; Knight R; Ariti C; Clayton T; Yellon DM;
Clin Res Cardiol; 2012 May; 101(5):339-48. PubMed ID: 22186969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
